Compare MRVI & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | CDZI |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.0M | 444.6M |
| IPO Year | 2020 | N/A |
| Metric | MRVI | CDZI |
|---|---|---|
| Price | $3.80 | $6.50 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.57 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 884.5K |
| Earning Date | 02-24-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $192,435,000.00 | $15,979,000.00 |
| Revenue This Year | N/A | $58.18 |
| Revenue Next Year | $10.00 | $32.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 188.33 |
| 52 Week Low | $1.67 | $2.13 |
| 52 Week High | $6.05 | $6.96 |
| Indicator | MRVI | CDZI |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 56.87 |
| Support Level | $3.66 | $6.21 |
| Resistance Level | $3.99 | $6.91 |
| Average True Range (ATR) | 0.18 | 0.45 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 34.78 | 65.63 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.